• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

May 5, 2011: Dietary Supplements Manufacturer Sentenced

OCI Small Clear Seal 

 


 

 

 

Food and Drug Administration 
Office of Criminal Investigations

 


 

 

             U.S. Department of Justice Press Release

 

 

For Immediate Release

May 5, 2011

 

United States Attorney 

District of Idaho

Contact: Pamela Bearg

Public Information Officer

(208) 334-1211

 

 

Tribravus Enterprises, LLC, dba IForce Nutrition, was sentenced today in federal court in Boise for causing purported dietary supplements to be unlawfully manufactured and distributed in interstate commerce, U.S. Attorney Wendy J. Olson announced. Chief U.S. District Judge B. Lynn Winmill sentenced Tribravus to three years probation; a $125,000 fine, payable in installments, and a $400 special assessment. As conditions of probation, the court ordered future financial disclosures and a monitoring and testing protocol that includes testing of all products distributed by Tribravus / IForce for banned steroids.
 
According to the plea agreement, Tribravus / IForce distributed the products “17aPheraFLEX,” “Dymethazine” and “Methadrol” as dietary supplements. The FDA found that these products contained synthetic steroids, known as “DMT” or “Madol” and “Superdrol.” Thus they were not dietary supplements but rather unapproved drugs under the Food, Drug and Cosmetic Act. Tribravus Enterprises agreed to pay the $125,000 fine and implement a testing protocol for its products to ensure future products sold as dietary supplements do not contain synthetic steroids.
 
Tribravus Enterprises is organized in Arizona and does business as IForce Nutrition in Vista, California. The charges were brought in federal court in Idaho because Tribravus delivered its products to a retail company located in Idaho for further distribution throughout the United States.
 
The case was investigated by the Food and Drug Administration, Office of Criminal Investigations.